Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
Regulatory Info : Schedule D
Registration Country : Canada
HEPATITIS B IMMUNOGLOBULIN (HUMAN)
Brand Name : HYPERHEP B
Dosage Form : SOLUTION
Dosage Strength : 220UNIT/ML
Packaging :
Approval Date :
Application Number : 2520001
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
HEPATITIS B IMMUNOGLOBULIN (HUMAN)
Brand Name : HYPERHEP B
Dosage Form : SOLUTION
Dosage Strength : 110UNIT/0.5ML
Packaging :
Approval Date :
Application Number : 2520125
Regulatory Info : Schedule D
Registration Country : Canada
Regulatory Info : Schedule D
Registration Country : Canada
HEPATITIS B IMMUNOGLOBULIN (HUMAN)
Brand Name : HEPAGAM B
Dosage Form : SOLUTION
Dosage Strength : 312UNIT/ML
Packaging :
Approval Date :
Application Number : 2290979
Regulatory Info : Schedule D
Registration Country : Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
